Ventricular Assist Devices Comprehensive Study by Type (Left ventricular assist device (LVAD), Right ventricular assist device (RVAD), Others), Application (Bridge to transplant, Destination therapy, Bridge to recovery, Others), Design (Implantable Ventricular Assist Device, Transcutaneous Ventricular Assist Device), Circulation Flow (Axial Flow, Centrifugal Flow), End User (Hospitals, Ambulatory Surgical Centers, Cardiology Centers) Players and Region - Global Market Outlook to 2026

Ventricular Assist Devices Market by XX Submarkets | Forecast Years 2021-2026  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Ventricular Assist Devices Market Scope
A ventricular assist device (VAD), also known as a mechanical circulatory support device, is a device that assists in the pumping of blood from your heart's lower chambers (ventricles) to the rest of your body. You may require surgery to implant a VAD while you wait for a heart transplant or to help your heart produce enough blood flow permanently. Although a VAD can be implanted in either of your heart's ventricles, it is most commonly implanted in the left ventricle. It is known as a left ventricular assist device when it is placed in the left ventricle (LVAD). Current LVADs keep blood flowing from your heart to your body at all times. These LVADs are known as continuous flow devices. The procedure to implant a VAD frequently necessitates open-heart surgery and carries serious risks. However, if you have severe heart failure, a VAD can save your life.

AttributesDetails
Study Period2016-2026
Base Year2020
UnitValue (USD Million)
Key Companies ProfiledAbiomed (Japan), Medtronic (Ireland), Abbott (United States), Berlin Heart (Germany), Cardiac Assist, Inc. (United States), Jarvik Heart, Inc. (United States), ReliantHeart, Inc. (United States), HI-LEX (Sun Medical Technology Research Corp.) (Japan), LIVANOVA PLC (United Kingdom), Thoratec Corporation (United States), CorWave (France) and Suzhou Tongxin Medical Equipment Co., Ltd. (China)
CAGR%


To entice more end users, market players are focusing on providing ventricular assist devices of higher quality while adhering to all regulatory standards. In the global ventricular assist devices market; there are numerous large and small-scale service providers. They are also concentrating on the implementation of numerous advanced technologies. Furthermore, the numerous industry profits have led to the entry of new players, raising the level of rivalry in an already competitive market. The ventricular assist devices market is currently expanding due to the rapid advancement of technology in IoT and AIML in healthcare. Some of the key players in this market follow strategies, which include new product offerings, product approvals, partnerships and alliances, mergers and acquisitions, and business expansions.

Abiomed (Japan), Medtronic (Ireland), Abbott (United States), Berlin Heart (Germany), Cardiac Assist, Inc. (United States), Jarvik Heart, Inc. (United States), ReliantHeart, Inc. (United States), HI-LEX (Sun Medical Technology Research Corp.) (Japan), LIVANOVA PLC (United Kingdom), Thoratec Corporation (United States), CorWave (France) and Suzhou Tongxin Medical Equipment Co., Ltd. (China) are some of the key players that are part of study coverage.

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Ventricular Assist Devices market by Type , by Application (Bridge to transplant, Destination therapy, Bridge to recovery and Others) and Region with country level break-up.

On the basis of geography, the market of Ventricular Assist Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2020.

Market Leaders and their expansionary development strategies
In June 2021, Abiomed has acquired preCARDIA, the developer of a proprietary catheter and controller that will complement Abiomedís product portfolio to expand options for patients with acute decompensated heart failure (ADHF). The preCARDIA system is uniquely designed to rapidly treat ADHF-related volume overload by effectively reducing cardiac filling pressures and promoting decongestion to improve overall cardiac and renal function.
In June 2021, The US Food and Drug Administration (FDA) granted pre-market approval (PMA) to Abiomedís latest heart pump, Impella RP with SmartAssist, for the treatment of acute right heart failure for up to 14 days. The device is approved for treating patients with a body surface area greater than or equal to 1.5m≤ with acute right heart failure or decompensation after implanting a left ventricular assist device, myocardial infarction, heart transplant, or open-heart surgery.
In June 2021, the U.S. Food and Drug Administration is alerting health care providers to no longer implant end-stage heart failure patients with Medtronicís Heartware Ventricular Assist Device (HVAD) System due to a growing body of observational clinical comparisons that demonstrates a higher frequency of neurological adverse events and mortality associated with the system when compared to other commercially available devices, as well as complaints that the internal pump may delay or fail to restart.

Ventricular Assist Devices Market Dynamics:
AttributesDetails
Trends Influencing Market
  • Increasing Incidence of the Heart Failure to Foster Adoption of These Devices
Key Restraints
  • Side Effects Associated with These Devices to Hinder the Market Growth.
Challenges
  • Less Developed Healthcare Infrastructure in Developing Countries Would Affect the Market Growth.
Market Opportunities
  • Technological Advancements in the Healthcare Industry with AIML will be Bringing More Opportunities for Market Growth.


Key Target Audience
Healthcare device manufacturers, New Entrants and Investors, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

Report Objectives / Segmentation Covered

By Type
  • Left ventricular assist device (LVAD)
  • Right ventricular assist device (RVAD)
  • Others
By Application
  • Bridge to transplant
  • Destination therapy
  • Bridge to recovery
  • Others
By Design
  • Implantable Ventricular Assist Device
  • Transcutaneous Ventricular Assist Device

By Circulation Flow
  • Axial Flow
  • Centrifugal Flow

By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiology Centers

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Technological Developments and Geriatric Population Is Driving the Demand for Ventricular Assist Devices
    • 3.3. Market Challenges
      • 3.3.1. Less Developed Healthcare Infrastructure in Developing Countries Would Affect the Market Growth.
    • 3.4. Market Trends
      • 3.4.1. Increasing Incidence of the Heart Failure to Foster Adoption of These Devices
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Ventricular Assist Devices, by Type, Application, Design, Circulation Flow, End User and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Ventricular Assist Devices (Value)
      • 5.2.1. Global Ventricular Assist Devices by: Type (Value)
        • 5.2.1.1. Left ventricular assist device (LVAD)
        • 5.2.1.2. Right ventricular assist device (RVAD)
        • 5.2.1.3. Others
      • 5.2.2. Global Ventricular Assist Devices by: Application (Value)
        • 5.2.2.1. Bridge to transplant
        • 5.2.2.2. Destination therapy
        • 5.2.2.3. Bridge to recovery
        • 5.2.2.4. Others
      • 5.2.3. Global Ventricular Assist Devices by: Design (Value)
        • 5.2.3.1. Implantable Ventricular Assist Device
        • 5.2.3.2. Transcutaneous Ventricular Assist Device
      • 5.2.4. Global Ventricular Assist Devices by: Circulation Flow (Value)
        • 5.2.4.1. Axial Flow
        • 5.2.4.2. Centrifugal Flow
      • 5.2.5. Global Ventricular Assist Devices by: End User (Value)
        • 5.2.5.1. Hospitals
        • 5.2.5.2. Ambulatory Surgical Centers
        • 5.2.5.3. Cardiology Centers
      • 5.2.6. Global Ventricular Assist Devices Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Ventricular Assist Devices (Price)
      • 5.3.1. Global Ventricular Assist Devices by: Type (Price)
  • 6. Ventricular Assist Devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abiomed (Japan)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Medtronic (Ireland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Abbott (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Berlin Heart (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Cardiac Assist, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Jarvik Heart, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. ReliantHeart, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. HI-LEX (Sun Medical Technology Research Corp.) (Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. LIVANOVA PLC (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Thoratec Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. CorWave (France)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Suzhou Tongxin Medical Equipment Co., Ltd. (China)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Ventricular Assist Devices Sale, by Type, Application, Design, Circulation Flow, End User and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Ventricular Assist Devices (Value)
      • 7.2.1. Global Ventricular Assist Devices by: Type (Value)
        • 7.2.1.1. Left ventricular assist device (LVAD)
        • 7.2.1.2. Right ventricular assist device (RVAD)
        • 7.2.1.3. Others
      • 7.2.2. Global Ventricular Assist Devices by: Application (Value)
        • 7.2.2.1. Bridge to transplant
        • 7.2.2.2. Destination therapy
        • 7.2.2.3. Bridge to recovery
        • 7.2.2.4. Others
      • 7.2.3. Global Ventricular Assist Devices by: Design (Value)
        • 7.2.3.1. Implantable Ventricular Assist Device
        • 7.2.3.2. Transcutaneous Ventricular Assist Device
      • 7.2.4. Global Ventricular Assist Devices by: Circulation Flow (Value)
        • 7.2.4.1. Axial Flow
        • 7.2.4.2. Centrifugal Flow
      • 7.2.5. Global Ventricular Assist Devices by: End User (Value)
        • 7.2.5.1. Hospitals
        • 7.2.5.2. Ambulatory Surgical Centers
        • 7.2.5.3. Cardiology Centers
      • 7.2.6. Global Ventricular Assist Devices Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Ventricular Assist Devices (Price)
      • 7.3.1. Global Ventricular Assist Devices by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Ventricular Assist Devices: by Type(USD Million)
  • Table 2. Ventricular Assist Devices Left ventricular assist device (LVAD) , by Region USD Million (2015-2020)
  • Table 3. Ventricular Assist Devices Right ventricular assist device (RVAD) , by Region USD Million (2015-2020)
  • Table 4. Ventricular Assist Devices Others , by Region USD Million (2015-2020)
  • Table 5. Ventricular Assist Devices: by Application(USD Million)
  • Table 6. Ventricular Assist Devices Bridge to transplant , by Region USD Million (2015-2020)
  • Table 7. Ventricular Assist Devices Destination therapy , by Region USD Million (2015-2020)
  • Table 8. Ventricular Assist Devices Bridge to recovery , by Region USD Million (2015-2020)
  • Table 9. Ventricular Assist Devices Others , by Region USD Million (2015-2020)
  • Table 10. Ventricular Assist Devices: by Design(USD Million)
  • Table 11. Ventricular Assist Devices Implantable Ventricular Assist Device , by Region USD Million (2015-2020)
  • Table 12. Ventricular Assist Devices Transcutaneous Ventricular Assist Device , by Region USD Million (2015-2020)
  • Table 13. Ventricular Assist Devices: by Circulation Flow(USD Million)
  • Table 14. Ventricular Assist Devices Axial Flow , by Region USD Million (2015-2020)
  • Table 15. Ventricular Assist Devices Centrifugal Flow , by Region USD Million (2015-2020)
  • Table 16. Ventricular Assist Devices: by End User(USD Million)
  • Table 17. Ventricular Assist Devices Hospitals , by Region USD Million (2015-2020)
  • Table 18. Ventricular Assist Devices Ambulatory Surgical Centers , by Region USD Million (2015-2020)
  • Table 19. Ventricular Assist Devices Cardiology Centers , by Region USD Million (2015-2020)
  • Table 20. South America Ventricular Assist Devices, by Country USD Million (2015-2020)
  • Table 21. South America Ventricular Assist Devices, by Type USD Million (2015-2020)
  • Table 22. South America Ventricular Assist Devices, by Application USD Million (2015-2020)
  • Table 23. South America Ventricular Assist Devices, by Design USD Million (2015-2020)
  • Table 24. South America Ventricular Assist Devices, by Circulation Flow USD Million (2015-2020)
  • Table 25. South America Ventricular Assist Devices, by End User USD Million (2015-2020)
  • Table 26. Brazil Ventricular Assist Devices, by Type USD Million (2015-2020)
  • Table 27. Brazil Ventricular Assist Devices, by Application USD Million (2015-2020)
  • Table 28. Brazil Ventricular Assist Devices, by Design USD Million (2015-2020)
  • Table 29. Brazil Ventricular Assist Devices, by Circulation Flow USD Million (2015-2020)
  • Table 30. Brazil Ventricular Assist Devices, by End User USD Million (2015-2020)
  • Table 31. Argentina Ventricular Assist Devices, by Type USD Million (2015-2020)
  • Table 32. Argentina Ventricular Assist Devices, by Application USD Million (2015-2020)
  • Table 33. Argentina Ventricular Assist Devices, by Design USD Million (2015-2020)
  • Table 34. Argentina Ventricular Assist Devices, by Circulation Flow USD Million (2015-2020)
  • Table 35. Argentina Ventricular Assist Devices, by End User USD Million (2015-2020)
  • Table 36. Rest of South America Ventricular Assist Devices, by Type USD Million (2015-2020)
  • Table 37. Rest of South America Ventricular Assist Devices, by Application USD Million (2015-2020)
  • Table 38. Rest of South America Ventricular Assist Devices, by Design USD Million (2015-2020)
  • Table 39. Rest of South America Ventricular Assist Devices, by Circulation Flow USD Million (2015-2020)
  • Table 40. Rest of South America Ventricular Assist Devices, by End User USD Million (2015-2020)
  • Table 41. Asia Pacific Ventricular Assist Devices, by Country USD Million (2015-2020)
  • Table 42. Asia Pacific Ventricular Assist Devices, by Type USD Million (2015-2020)
  • Table 43. Asia Pacific Ventricular Assist Devices, by Application USD Million (2015-2020)
  • Table 44. Asia Pacific Ventricular Assist Devices, by Design USD Million (2015-2020)
  • Table 45. Asia Pacific Ventricular Assist Devices, by Circulation Flow USD Million (2015-2020)
  • Table 46. Asia Pacific Ventricular Assist Devices, by End User USD Million (2015-2020)
  • Table 47. China Ventricular Assist Devices, by Type USD Million (2015-2020)
  • Table 48. China Ventricular Assist Devices, by Application USD Million (2015-2020)
  • Table 49. China Ventricular Assist Devices, by Design USD Million (2015-2020)
  • Table 50. China Ventricular Assist Devices, by Circulation Flow USD Million (2015-2020)
  • Table 51. China Ventricular Assist Devices, by End User USD Million (2015-2020)
  • Table 52. Japan Ventricular Assist Devices, by Type USD Million (2015-2020)
  • Table 53. Japan Ventricular Assist Devices, by Application USD Million (2015-2020)
  • Table 54. Japan Ventricular Assist Devices, by Design USD Million (2015-2020)
  • Table 55. Japan Ventricular Assist Devices, by Circulation Flow USD Million (2015-2020)
  • Table 56. Japan Ventricular Assist Devices, by End User USD Million (2015-2020)
  • Table 57. India Ventricular Assist Devices, by Type USD Million (2015-2020)
  • Table 58. India Ventricular Assist Devices, by Application USD Million (2015-2020)
  • Table 59. India Ventricular Assist Devices, by Design USD Million (2015-2020)
  • Table 60. India Ventricular Assist Devices, by Circulation Flow USD Million (2015-2020)
  • Table 61. India Ventricular Assist Devices, by End User USD Million (2015-2020)
  • Table 62. South Korea Ventricular Assist Devices, by Type USD Million (2015-2020)
  • Table 63. South Korea Ventricular Assist Devices, by Application USD Million (2015-2020)
  • Table 64. South Korea Ventricular Assist Devices, by Design USD Million (2015-2020)
  • Table 65. South Korea Ventricular Assist Devices, by Circulation Flow USD Million (2015-2020)
  • Table 66. South Korea Ventricular Assist Devices, by End User USD Million (2015-2020)
  • Table 67. Taiwan Ventricular Assist Devices, by Type USD Million (2015-2020)
  • Table 68. Taiwan Ventricular Assist Devices, by Application USD Million (2015-2020)
  • Table 69. Taiwan Ventricular Assist Devices, by Design USD Million (2015-2020)
  • Table 70. Taiwan Ventricular Assist Devices, by Circulation Flow USD Million (2015-2020)
  • Table 71. Taiwan Ventricular Assist Devices, by End User USD Million (2015-2020)
  • Table 72. Australia Ventricular Assist Devices, by Type USD Million (2015-2020)
  • Table 73. Australia Ventricular Assist Devices, by Application USD Million (2015-2020)
  • Table 74. Australia Ventricular Assist Devices, by Design USD Million (2015-2020)
  • Table 75. Australia Ventricular Assist Devices, by Circulation Flow USD Million (2015-2020)
  • Table 76. Australia Ventricular Assist Devices, by End User USD Million (2015-2020)
  • Table 77. Rest of Asia-Pacific Ventricular Assist Devices, by Type USD Million (2015-2020)
  • Table 78. Rest of Asia-Pacific Ventricular Assist Devices, by Application USD Million (2015-2020)
  • Table 79. Rest of Asia-Pacific Ventricular Assist Devices, by Design USD Million (2015-2020)
  • Table 80. Rest of Asia-Pacific Ventricular Assist Devices, by Circulation Flow USD Million (2015-2020)
  • Table 81. Rest of Asia-Pacific Ventricular Assist Devices, by End User USD Million (2015-2020)
  • Table 82. Europe Ventricular Assist Devices, by Country USD Million (2015-2020)
  • Table 83. Europe Ventricular Assist Devices, by Type USD Million (2015-2020)
  • Table 84. Europe Ventricular Assist Devices, by Application USD Million (2015-2020)
  • Table 85. Europe Ventricular Assist Devices, by Design USD Million (2015-2020)
  • Table 86. Europe Ventricular Assist Devices, by Circulation Flow USD Million (2015-2020)
  • Table 87. Europe Ventricular Assist Devices, by End User USD Million (2015-2020)
  • Table 88. Germany Ventricular Assist Devices, by Type USD Million (2015-2020)
  • Table 89. Germany Ventricular Assist Devices, by Application USD Million (2015-2020)
  • Table 90. Germany Ventricular Assist Devices, by Design USD Million (2015-2020)
  • Table 91. Germany Ventricular Assist Devices, by Circulation Flow USD Million (2015-2020)
  • Table 92. Germany Ventricular Assist Devices, by End User USD Million (2015-2020)
  • Table 93. France Ventricular Assist Devices, by Type USD Million (2015-2020)
  • Table 94. France Ventricular Assist Devices, by Application USD Million (2015-2020)
  • Table 95. France Ventricular Assist Devices, by Design USD Million (2015-2020)
  • Table 96. France Ventricular Assist Devices, by Circulation Flow USD Million (2015-2020)
  • Table 97. France Ventricular Assist Devices, by End User USD Million (2015-2020)
  • Table 98. Italy Ventricular Assist Devices, by Type USD Million (2015-2020)
  • Table 99. Italy Ventricular Assist Devices, by Application USD Million (2015-2020)
  • Table 100. Italy Ventricular Assist Devices, by Design USD Million (2015-2020)
  • Table 101. Italy Ventricular Assist Devices, by Circulation Flow USD Million (2015-2020)
  • Table 102. Italy Ventricular Assist Devices, by End User USD Million (2015-2020)
  • Table 103. United Kingdom Ventricular Assist Devices, by Type USD Million (2015-2020)
  • Table 104. United Kingdom Ventricular Assist Devices, by Application USD Million (2015-2020)
  • Table 105. United Kingdom Ventricular Assist Devices, by Design USD Million (2015-2020)
  • Table 106. United Kingdom Ventricular Assist Devices, by Circulation Flow USD Million (2015-2020)
  • Table 107. United Kingdom Ventricular Assist Devices, by End User USD Million (2015-2020)
  • Table 108. Netherlands Ventricular Assist Devices, by Type USD Million (2015-2020)
  • Table 109. Netherlands Ventricular Assist Devices, by Application USD Million (2015-2020)
  • Table 110. Netherlands Ventricular Assist Devices, by Design USD Million (2015-2020)
  • Table 111. Netherlands Ventricular Assist Devices, by Circulation Flow USD Million (2015-2020)
  • Table 112. Netherlands Ventricular Assist Devices, by End User USD Million (2015-2020)
  • Table 113. Rest of Europe Ventricular Assist Devices, by Type USD Million (2015-2020)
  • Table 114. Rest of Europe Ventricular Assist Devices, by Application USD Million (2015-2020)
  • Table 115. Rest of Europe Ventricular Assist Devices, by Design USD Million (2015-2020)
  • Table 116. Rest of Europe Ventricular Assist Devices, by Circulation Flow USD Million (2015-2020)
  • Table 117. Rest of Europe Ventricular Assist Devices, by End User USD Million (2015-2020)
  • Table 118. MEA Ventricular Assist Devices, by Country USD Million (2015-2020)
  • Table 119. MEA Ventricular Assist Devices, by Type USD Million (2015-2020)
  • Table 120. MEA Ventricular Assist Devices, by Application USD Million (2015-2020)
  • Table 121. MEA Ventricular Assist Devices, by Design USD Million (2015-2020)
  • Table 122. MEA Ventricular Assist Devices, by Circulation Flow USD Million (2015-2020)
  • Table 123. MEA Ventricular Assist Devices, by End User USD Million (2015-2020)
  • Table 124. Middle East Ventricular Assist Devices, by Type USD Million (2015-2020)
  • Table 125. Middle East Ventricular Assist Devices, by Application USD Million (2015-2020)
  • Table 126. Middle East Ventricular Assist Devices, by Design USD Million (2015-2020)
  • Table 127. Middle East Ventricular Assist Devices, by Circulation Flow USD Million (2015-2020)
  • Table 128. Middle East Ventricular Assist Devices, by End User USD Million (2015-2020)
  • Table 129. Africa Ventricular Assist Devices, by Type USD Million (2015-2020)
  • Table 130. Africa Ventricular Assist Devices, by Application USD Million (2015-2020)
  • Table 131. Africa Ventricular Assist Devices, by Design USD Million (2015-2020)
  • Table 132. Africa Ventricular Assist Devices, by Circulation Flow USD Million (2015-2020)
  • Table 133. Africa Ventricular Assist Devices, by End User USD Million (2015-2020)
  • Table 134. North America Ventricular Assist Devices, by Country USD Million (2015-2020)
  • Table 135. North America Ventricular Assist Devices, by Type USD Million (2015-2020)
  • Table 136. North America Ventricular Assist Devices, by Application USD Million (2015-2020)
  • Table 137. North America Ventricular Assist Devices, by Design USD Million (2015-2020)
  • Table 138. North America Ventricular Assist Devices, by Circulation Flow USD Million (2015-2020)
  • Table 139. North America Ventricular Assist Devices, by End User USD Million (2015-2020)
  • Table 140. United States Ventricular Assist Devices, by Type USD Million (2015-2020)
  • Table 141. United States Ventricular Assist Devices, by Application USD Million (2015-2020)
  • Table 142. United States Ventricular Assist Devices, by Design USD Million (2015-2020)
  • Table 143. United States Ventricular Assist Devices, by Circulation Flow USD Million (2015-2020)
  • Table 144. United States Ventricular Assist Devices, by End User USD Million (2015-2020)
  • Table 145. Canada Ventricular Assist Devices, by Type USD Million (2015-2020)
  • Table 146. Canada Ventricular Assist Devices, by Application USD Million (2015-2020)
  • Table 147. Canada Ventricular Assist Devices, by Design USD Million (2015-2020)
  • Table 148. Canada Ventricular Assist Devices, by Circulation Flow USD Million (2015-2020)
  • Table 149. Canada Ventricular Assist Devices, by End User USD Million (2015-2020)
  • Table 150. Mexico Ventricular Assist Devices, by Type USD Million (2015-2020)
  • Table 151. Mexico Ventricular Assist Devices, by Application USD Million (2015-2020)
  • Table 152. Mexico Ventricular Assist Devices, by Design USD Million (2015-2020)
  • Table 153. Mexico Ventricular Assist Devices, by Circulation Flow USD Million (2015-2020)
  • Table 154. Mexico Ventricular Assist Devices, by End User USD Million (2015-2020)
  • Table 155. Ventricular Assist Devices: by Type(USD/Units)
  • Table 156. Company Basic Information, Sales Area and Its Competitors
  • Table 157. Company Basic Information, Sales Area and Its Competitors
  • Table 158. Company Basic Information, Sales Area and Its Competitors
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Ventricular Assist Devices: by Type(USD Million)
  • Table 169. Ventricular Assist Devices Left ventricular assist device (LVAD) , by Region USD Million (2021-2026)
  • Table 170. Ventricular Assist Devices Right ventricular assist device (RVAD) , by Region USD Million (2021-2026)
  • Table 171. Ventricular Assist Devices Others , by Region USD Million (2021-2026)
  • Table 172. Ventricular Assist Devices: by Application(USD Million)
  • Table 173. Ventricular Assist Devices Bridge to transplant , by Region USD Million (2021-2026)
  • Table 174. Ventricular Assist Devices Destination therapy , by Region USD Million (2021-2026)
  • Table 175. Ventricular Assist Devices Bridge to recovery , by Region USD Million (2021-2026)
  • Table 176. Ventricular Assist Devices Others , by Region USD Million (2021-2026)
  • Table 177. Ventricular Assist Devices: by Design(USD Million)
  • Table 178. Ventricular Assist Devices Implantable Ventricular Assist Device , by Region USD Million (2021-2026)
  • Table 179. Ventricular Assist Devices Transcutaneous Ventricular Assist Device , by Region USD Million (2021-2026)
  • Table 180. Ventricular Assist Devices: by Circulation Flow(USD Million)
  • Table 181. Ventricular Assist Devices Axial Flow , by Region USD Million (2021-2026)
  • Table 182. Ventricular Assist Devices Centrifugal Flow , by Region USD Million (2021-2026)
  • Table 183. Ventricular Assist Devices: by End User(USD Million)
  • Table 184. Ventricular Assist Devices Hospitals , by Region USD Million (2021-2026)
  • Table 185. Ventricular Assist Devices Ambulatory Surgical Centers , by Region USD Million (2021-2026)
  • Table 186. Ventricular Assist Devices Cardiology Centers , by Region USD Million (2021-2026)
  • Table 187. South America Ventricular Assist Devices, by Country USD Million (2021-2026)
  • Table 188. South America Ventricular Assist Devices, by Type USD Million (2021-2026)
  • Table 189. South America Ventricular Assist Devices, by Application USD Million (2021-2026)
  • Table 190. South America Ventricular Assist Devices, by Design USD Million (2021-2026)
  • Table 191. South America Ventricular Assist Devices, by Circulation Flow USD Million (2021-2026)
  • Table 192. South America Ventricular Assist Devices, by End User USD Million (2021-2026)
  • Table 193. Brazil Ventricular Assist Devices, by Type USD Million (2021-2026)
  • Table 194. Brazil Ventricular Assist Devices, by Application USD Million (2021-2026)
  • Table 195. Brazil Ventricular Assist Devices, by Design USD Million (2021-2026)
  • Table 196. Brazil Ventricular Assist Devices, by Circulation Flow USD Million (2021-2026)
  • Table 197. Brazil Ventricular Assist Devices, by End User USD Million (2021-2026)
  • Table 198. Argentina Ventricular Assist Devices, by Type USD Million (2021-2026)
  • Table 199. Argentina Ventricular Assist Devices, by Application USD Million (2021-2026)
  • Table 200. Argentina Ventricular Assist Devices, by Design USD Million (2021-2026)
  • Table 201. Argentina Ventricular Assist Devices, by Circulation Flow USD Million (2021-2026)
  • Table 202. Argentina Ventricular Assist Devices, by End User USD Million (2021-2026)
  • Table 203. Rest of South America Ventricular Assist Devices, by Type USD Million (2021-2026)
  • Table 204. Rest of South America Ventricular Assist Devices, by Application USD Million (2021-2026)
  • Table 205. Rest of South America Ventricular Assist Devices, by Design USD Million (2021-2026)
  • Table 206. Rest of South America Ventricular Assist Devices, by Circulation Flow USD Million (2021-2026)
  • Table 207. Rest of South America Ventricular Assist Devices, by End User USD Million (2021-2026)
  • Table 208. Asia Pacific Ventricular Assist Devices, by Country USD Million (2021-2026)
  • Table 209. Asia Pacific Ventricular Assist Devices, by Type USD Million (2021-2026)
  • Table 210. Asia Pacific Ventricular Assist Devices, by Application USD Million (2021-2026)
  • Table 211. Asia Pacific Ventricular Assist Devices, by Design USD Million (2021-2026)
  • Table 212. Asia Pacific Ventricular Assist Devices, by Circulation Flow USD Million (2021-2026)
  • Table 213. Asia Pacific Ventricular Assist Devices, by End User USD Million (2021-2026)
  • Table 214. China Ventricular Assist Devices, by Type USD Million (2021-2026)
  • Table 215. China Ventricular Assist Devices, by Application USD Million (2021-2026)
  • Table 216. China Ventricular Assist Devices, by Design USD Million (2021-2026)
  • Table 217. China Ventricular Assist Devices, by Circulation Flow USD Million (2021-2026)
  • Table 218. China Ventricular Assist Devices, by End User USD Million (2021-2026)
  • Table 219. Japan Ventricular Assist Devices, by Type USD Million (2021-2026)
  • Table 220. Japan Ventricular Assist Devices, by Application USD Million (2021-2026)
  • Table 221. Japan Ventricular Assist Devices, by Design USD Million (2021-2026)
  • Table 222. Japan Ventricular Assist Devices, by Circulation Flow USD Million (2021-2026)
  • Table 223. Japan Ventricular Assist Devices, by End User USD Million (2021-2026)
  • Table 224. India Ventricular Assist Devices, by Type USD Million (2021-2026)
  • Table 225. India Ventricular Assist Devices, by Application USD Million (2021-2026)
  • Table 226. India Ventricular Assist Devices, by Design USD Million (2021-2026)
  • Table 227. India Ventricular Assist Devices, by Circulation Flow USD Million (2021-2026)
  • Table 228. India Ventricular Assist Devices, by End User USD Million (2021-2026)
  • Table 229. South Korea Ventricular Assist Devices, by Type USD Million (2021-2026)
  • Table 230. South Korea Ventricular Assist Devices, by Application USD Million (2021-2026)
  • Table 231. South Korea Ventricular Assist Devices, by Design USD Million (2021-2026)
  • Table 232. South Korea Ventricular Assist Devices, by Circulation Flow USD Million (2021-2026)
  • Table 233. South Korea Ventricular Assist Devices, by End User USD Million (2021-2026)
  • Table 234. Taiwan Ventricular Assist Devices, by Type USD Million (2021-2026)
  • Table 235. Taiwan Ventricular Assist Devices, by Application USD Million (2021-2026)
  • Table 236. Taiwan Ventricular Assist Devices, by Design USD Million (2021-2026)
  • Table 237. Taiwan Ventricular Assist Devices, by Circulation Flow USD Million (2021-2026)
  • Table 238. Taiwan Ventricular Assist Devices, by End User USD Million (2021-2026)
  • Table 239. Australia Ventricular Assist Devices, by Type USD Million (2021-2026)
  • Table 240. Australia Ventricular Assist Devices, by Application USD Million (2021-2026)
  • Table 241. Australia Ventricular Assist Devices, by Design USD Million (2021-2026)
  • Table 242. Australia Ventricular Assist Devices, by Circulation Flow USD Million (2021-2026)
  • Table 243. Australia Ventricular Assist Devices, by End User USD Million (2021-2026)
  • Table 244. Rest of Asia-Pacific Ventricular Assist Devices, by Type USD Million (2021-2026)
  • Table 245. Rest of Asia-Pacific Ventricular Assist Devices, by Application USD Million (2021-2026)
  • Table 246. Rest of Asia-Pacific Ventricular Assist Devices, by Design USD Million (2021-2026)
  • Table 247. Rest of Asia-Pacific Ventricular Assist Devices, by Circulation Flow USD Million (2021-2026)
  • Table 248. Rest of Asia-Pacific Ventricular Assist Devices, by End User USD Million (2021-2026)
  • Table 249. Europe Ventricular Assist Devices, by Country USD Million (2021-2026)
  • Table 250. Europe Ventricular Assist Devices, by Type USD Million (2021-2026)
  • Table 251. Europe Ventricular Assist Devices, by Application USD Million (2021-2026)
  • Table 252. Europe Ventricular Assist Devices, by Design USD Million (2021-2026)
  • Table 253. Europe Ventricular Assist Devices, by Circulation Flow USD Million (2021-2026)
  • Table 254. Europe Ventricular Assist Devices, by End User USD Million (2021-2026)
  • Table 255. Germany Ventricular Assist Devices, by Type USD Million (2021-2026)
  • Table 256. Germany Ventricular Assist Devices, by Application USD Million (2021-2026)
  • Table 257. Germany Ventricular Assist Devices, by Design USD Million (2021-2026)
  • Table 258. Germany Ventricular Assist Devices, by Circulation Flow USD Million (2021-2026)
  • Table 259. Germany Ventricular Assist Devices, by End User USD Million (2021-2026)
  • Table 260. France Ventricular Assist Devices, by Type USD Million (2021-2026)
  • Table 261. France Ventricular Assist Devices, by Application USD Million (2021-2026)
  • Table 262. France Ventricular Assist Devices, by Design USD Million (2021-2026)
  • Table 263. France Ventricular Assist Devices, by Circulation Flow USD Million (2021-2026)
  • Table 264. France Ventricular Assist Devices, by End User USD Million (2021-2026)
  • Table 265. Italy Ventricular Assist Devices, by Type USD Million (2021-2026)
  • Table 266. Italy Ventricular Assist Devices, by Application USD Million (2021-2026)
  • Table 267. Italy Ventricular Assist Devices, by Design USD Million (2021-2026)
  • Table 268. Italy Ventricular Assist Devices, by Circulation Flow USD Million (2021-2026)
  • Table 269. Italy Ventricular Assist Devices, by End User USD Million (2021-2026)
  • Table 270. United Kingdom Ventricular Assist Devices, by Type USD Million (2021-2026)
  • Table 271. United Kingdom Ventricular Assist Devices, by Application USD Million (2021-2026)
  • Table 272. United Kingdom Ventricular Assist Devices, by Design USD Million (2021-2026)
  • Table 273. United Kingdom Ventricular Assist Devices, by Circulation Flow USD Million (2021-2026)
  • Table 274. United Kingdom Ventricular Assist Devices, by End User USD Million (2021-2026)
  • Table 275. Netherlands Ventricular Assist Devices, by Type USD Million (2021-2026)
  • Table 276. Netherlands Ventricular Assist Devices, by Application USD Million (2021-2026)
  • Table 277. Netherlands Ventricular Assist Devices, by Design USD Million (2021-2026)
  • Table 278. Netherlands Ventricular Assist Devices, by Circulation Flow USD Million (2021-2026)
  • Table 279. Netherlands Ventricular Assist Devices, by End User USD Million (2021-2026)
  • Table 280. Rest of Europe Ventricular Assist Devices, by Type USD Million (2021-2026)
  • Table 281. Rest of Europe Ventricular Assist Devices, by Application USD Million (2021-2026)
  • Table 282. Rest of Europe Ventricular Assist Devices, by Design USD Million (2021-2026)
  • Table 283. Rest of Europe Ventricular Assist Devices, by Circulation Flow USD Million (2021-2026)
  • Table 284. Rest of Europe Ventricular Assist Devices, by End User USD Million (2021-2026)
  • Table 285. MEA Ventricular Assist Devices, by Country USD Million (2021-2026)
  • Table 286. MEA Ventricular Assist Devices, by Type USD Million (2021-2026)
  • Table 287. MEA Ventricular Assist Devices, by Application USD Million (2021-2026)
  • Table 288. MEA Ventricular Assist Devices, by Design USD Million (2021-2026)
  • Table 289. MEA Ventricular Assist Devices, by Circulation Flow USD Million (2021-2026)
  • Table 290. MEA Ventricular Assist Devices, by End User USD Million (2021-2026)
  • Table 291. Middle East Ventricular Assist Devices, by Type USD Million (2021-2026)
  • Table 292. Middle East Ventricular Assist Devices, by Application USD Million (2021-2026)
  • Table 293. Middle East Ventricular Assist Devices, by Design USD Million (2021-2026)
  • Table 294. Middle East Ventricular Assist Devices, by Circulation Flow USD Million (2021-2026)
  • Table 295. Middle East Ventricular Assist Devices, by End User USD Million (2021-2026)
  • Table 296. Africa Ventricular Assist Devices, by Type USD Million (2021-2026)
  • Table 297. Africa Ventricular Assist Devices, by Application USD Million (2021-2026)
  • Table 298. Africa Ventricular Assist Devices, by Design USD Million (2021-2026)
  • Table 299. Africa Ventricular Assist Devices, by Circulation Flow USD Million (2021-2026)
  • Table 300. Africa Ventricular Assist Devices, by End User USD Million (2021-2026)
  • Table 301. North America Ventricular Assist Devices, by Country USD Million (2021-2026)
  • Table 302. North America Ventricular Assist Devices, by Type USD Million (2021-2026)
  • Table 303. North America Ventricular Assist Devices, by Application USD Million (2021-2026)
  • Table 304. North America Ventricular Assist Devices, by Design USD Million (2021-2026)
  • Table 305. North America Ventricular Assist Devices, by Circulation Flow USD Million (2021-2026)
  • Table 306. North America Ventricular Assist Devices, by End User USD Million (2021-2026)
  • Table 307. United States Ventricular Assist Devices, by Type USD Million (2021-2026)
  • Table 308. United States Ventricular Assist Devices, by Application USD Million (2021-2026)
  • Table 309. United States Ventricular Assist Devices, by Design USD Million (2021-2026)
  • Table 310. United States Ventricular Assist Devices, by Circulation Flow USD Million (2021-2026)
  • Table 311. United States Ventricular Assist Devices, by End User USD Million (2021-2026)
  • Table 312. Canada Ventricular Assist Devices, by Type USD Million (2021-2026)
  • Table 313. Canada Ventricular Assist Devices, by Application USD Million (2021-2026)
  • Table 314. Canada Ventricular Assist Devices, by Design USD Million (2021-2026)
  • Table 315. Canada Ventricular Assist Devices, by Circulation Flow USD Million (2021-2026)
  • Table 316. Canada Ventricular Assist Devices, by End User USD Million (2021-2026)
  • Table 317. Mexico Ventricular Assist Devices, by Type USD Million (2021-2026)
  • Table 318. Mexico Ventricular Assist Devices, by Application USD Million (2021-2026)
  • Table 319. Mexico Ventricular Assist Devices, by Design USD Million (2021-2026)
  • Table 320. Mexico Ventricular Assist Devices, by Circulation Flow USD Million (2021-2026)
  • Table 321. Mexico Ventricular Assist Devices, by End User USD Million (2021-2026)
  • Table 322. Ventricular Assist Devices: by Type(USD/Units)
  • Table 323. Research Programs/Design for This Report
  • Table 324. Key Data Information from Secondary Sources
  • Table 325. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Ventricular Assist Devices: by Type USD Million (2015-2020)
  • Figure 5. Global Ventricular Assist Devices: by Application USD Million (2015-2020)
  • Figure 6. Global Ventricular Assist Devices: by Design USD Million (2015-2020)
  • Figure 7. Global Ventricular Assist Devices: by Circulation Flow USD Million (2015-2020)
  • Figure 8. Global Ventricular Assist Devices: by End User USD Million (2015-2020)
  • Figure 9. South America Ventricular Assist Devices Share (%), by Country
  • Figure 10. Asia Pacific Ventricular Assist Devices Share (%), by Country
  • Figure 11. Europe Ventricular Assist Devices Share (%), by Country
  • Figure 12. MEA Ventricular Assist Devices Share (%), by Country
  • Figure 13. North America Ventricular Assist Devices Share (%), by Country
  • Figure 14. Global Ventricular Assist Devices: by Type USD/Units (2015-2020)
  • Figure 15. Global Ventricular Assist Devices share by Players 2020 (%)
  • Figure 16. Global Ventricular Assist Devices share by Players (Top 3) 2020(%)
  • Figure 17. Global Ventricular Assist Devices share by Players (Top 5) 2020(%)
  • Figure 18. BCG Matrix for key Companies
  • Figure 19. Abiomed (Japan) Revenue, Net Income and Gross profit
  • Figure 20. Abiomed (Japan) Revenue: by Geography 2020
  • Figure 21. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 22. Medtronic (Ireland) Revenue: by Geography 2020
  • Figure 23. Abbott (United States) Revenue, Net Income and Gross profit
  • Figure 24. Abbott (United States) Revenue: by Geography 2020
  • Figure 25. Berlin Heart (Germany) Revenue, Net Income and Gross profit
  • Figure 26. Berlin Heart (Germany) Revenue: by Geography 2020
  • Figure 27. Cardiac Assist, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Cardiac Assist, Inc. (United States) Revenue: by Geography 2020
  • Figure 29. Jarvik Heart, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Jarvik Heart, Inc. (United States) Revenue: by Geography 2020
  • Figure 31. ReliantHeart, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. ReliantHeart, Inc. (United States) Revenue: by Geography 2020
  • Figure 33. HI-LEX (Sun Medical Technology Research Corp.) (Japan) Revenue, Net Income and Gross profit
  • Figure 34. HI-LEX (Sun Medical Technology Research Corp.) (Japan) Revenue: by Geography 2020
  • Figure 35. LIVANOVA PLC (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 36. LIVANOVA PLC (United Kingdom) Revenue: by Geography 2020
  • Figure 37. Thoratec Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 38. Thoratec Corporation (United States) Revenue: by Geography 2020
  • Figure 39. CorWave (France) Revenue, Net Income and Gross profit
  • Figure 40. CorWave (France) Revenue: by Geography 2020
  • Figure 41. Suzhou Tongxin Medical Equipment Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 42. Suzhou Tongxin Medical Equipment Co., Ltd. (China) Revenue: by Geography 2020
  • Figure 43. Global Ventricular Assist Devices: by Type USD Million (2021-2026)
  • Figure 44. Global Ventricular Assist Devices: by Application USD Million (2021-2026)
  • Figure 45. Global Ventricular Assist Devices: by Design USD Million (2021-2026)
  • Figure 46. Global Ventricular Assist Devices: by Circulation Flow USD Million (2021-2026)
  • Figure 47. Global Ventricular Assist Devices: by End User USD Million (2021-2026)
  • Figure 48. South America Ventricular Assist Devices Share (%), by Country
  • Figure 49. Asia Pacific Ventricular Assist Devices Share (%), by Country
  • Figure 50. Europe Ventricular Assist Devices Share (%), by Country
  • Figure 51. MEA Ventricular Assist Devices Share (%), by Country
  • Figure 52. North America Ventricular Assist Devices Share (%), by Country
  • Figure 53. Global Ventricular Assist Devices: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Abiomed (Japan)
  • Medtronic (Ireland)
  • Abbott (United States)
  • Berlin Heart (Germany)
  • Cardiac Assist, Inc. (United States)
  • Jarvik Heart, Inc. (United States)
  • ReliantHeart, Inc. (United States)
  • HI-LEX (Sun Medical Technology Research Corp.) (Japan)
  • LIVANOVA PLC (United Kingdom)
  • Thoratec Corporation (United States)
  • CorWave (France)
  • Suzhou Tongxin Medical Equipment Co., Ltd. (China)
Select User Access Type

Key Highlights of Report


Aug 2022 221 Pages 62 Tables Base Year: 2020 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Ventricular Assist Devices Market are by type [Left ventricular assist device (LVAD), Right ventricular assist device (RVAD) and Others], by end use application [Bridge to transplant, Destination therapy, Bridge to recovery and Others].
The Ventricular Assist Devices Market is gaining popularity and expected to see strong valuation by 2026.
  • Increasing Technological Developments and Geriatric Population Is Driving the Demand for Ventricular Assist Devices

Know More About Global Ventricular Assist Devices Report?